LOS ANGELES--(BUSINESS WIRE)--Neural Analytics, Inc., a medical device company developing and commercializing technologies to measure, diagnose and track brain health, today announced that Anjan Chatterji, Executive Vice President of Corporate Development and Strategy, and Henry Hewes, Vice President of Sales and Global Marketing, will present at the Needham & Company's 17th Annual Healthcare Conference on Wednesday, March 28, 2018 at 9 a.m. EDT, at the Westin Grand Central Hotel in New York. They will discuss the commercial and capital goals of the company since its recent closing of a $15M Series B financing.
About Neural Analytics, Inc.
Neural Analytics, Inc. was founded in 2013 to create products and services to measure, diagnose and track brain health. The company’s current focus is on acute ischemic stroke, traumatic brain injury and dementia. They combine leading data science with cutting edge hardware to allow first responders and clinicians to accurately assess and monitor brain health issues. Their devices are designed to be portable, autonomous, reliable and produce precise and objective physiological measurements for medical responder monitoring of neural disorders.
